Electrochemotherapy versus standard radiotherapy for the treatment of basal cell carcinoma

Brief summary (registry, in English)

To compare effect of electhrochemotherapy versus standard radiotherapy for the treatment of basal cell carcinomas less than 3 cm.

What you commit to

• Study type: Interventional · Phase 4
• Planned participants: 52
• 1 site in 1 country
• Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of EU CTIS (euclinicaltrials.eu). It describes the study design.

AI-kivonat: who the study is looking for

Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.

The trial is looking for adults with biopsy-confirmed basal cell carcinoma, a type of skin cancer, smaller than 3 cm. It compares electrochemotherapy with standard radiotherapy.

Age

Above 18 years

Sex

All sexes

Disease stage

Basal cell carcinoma confirmed by biopsy, under 3 cm, that can be treated with both radiotherapy and electrochemotherapy

Earlier treatment

Previous bleomycin above 200.000 Units/m2 is not allowed

Main reasons for not taking part

• Basal cell carcinoma that has spread (metastatic)
• Previous bleomycin above 200.000 Units/m2
• Previous severe allergic reaction to bleomycin
• Pregnancy or breast feeding
• Taking part in other trials with trial medication

Read by machine on 9 Nov 2026.

Who cannot take part

Copied verbatim from EU CTIS (euclinicaltrials.eu) and grouped by topic. Only the trial team decides who can take part.

Who the study is looking for

Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers

Full criteria on EU CTIS (euclinicaltrials.eu)

Sites (1)

Sites in registry order. Save your city in your profile to sort them by distance.

Are you the coordinator? Confirm the details